Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
BerGenBio ApS
APS
In liquidation
CVR 44311747
Njalsgade 21F, 2300
København S
Business and other management consultancy activities
·
NACE 7020
Est. 2023 · 2 years old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
BerGenBio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
2M
3M
5M
7M
6M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
DKK thousands
Item
2024
Gross profit
6.482
Staff expenses
-6.290
EBITDA
192
Depreciation & amort.
-0
EBIT
192
Net financials
10
Profit before tax
Balance sheet
DKK thousands
Item
2024
Total assets
606
Equity
187
Long-term debt
0
Short-term debt
418
Total debt
418
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
3.0%
This company
2024
2024
Soliditetsgrad
30.9%
This company
38.2%
Market median
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-09-19 – 2024-12-31
View
PDF
More on BerGenBio ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
202
Tax
48
Net profit
154
+19% vs market
2024
2024
Egenkapitalforrentning
82.1%
This company
18.4%
Market median
+346% vs market
2024
2024
Nettoresultatgrad (af bruttofortjeneste)
2.4%
This company
2024
2024
Aktivomsætning (af bruttofortjeneste)
10.70×
This company
2024
2024
Gæld/egenkapital
2.23×
This company
0.62×
Market median
-260% vs market
2024
2024